De Meyer
Christy De Meyer, Aalter BE
Patent application number | Description | Published |
---|---|---|
20100062242 | SOLAR CONTROL FILM - The invention relates to a solar control film comprising at least one infrared reflecting layer comprising a metal and at least one infrared absorbing layer comprising nanoparticles. The infrared absorbing layer is thereby located further from the sun than the infrared reflecting layer. By combining first reflection of the infrared energy and then absorption of the infrared energy, an optimum between reflection and absorption is obtained. | 03-11-2010 |
Christy De Meyer, Waregem BE
Patent application number | Description | Published |
---|---|---|
20090305013 | LAYERED STRUCTURE COMPRISING NANOPARTICLES - The invention relates to a layered structure comprising at least a first and a second layer whereby the refractive indices of the first and the second layer are matched to avoid iridescence by adding nanoparticles to at least one of the first or the second layer. The invention also relates to a window film comprising a substrate and a low iridescent coating. The invention further relates to a method to match the index of refractive indices of two layers thereby avoiding iridescence. | 12-10-2009 |
Herman Jozef Claudius De Meyer, Brasschaat BE
Patent application number | Description | Published |
---|---|---|
20090062563 | Process for Preparing Aromatic Carboxylic Acids - The present invention relates to a process for making terephthalic acid by reacting a starting material and oxygen in the presence of a heterogeneous catalyst and p-xylene as solvent to produce a solution of terephthalic acid (TPA). The starting material is p-xylene, p-toluic acid, 4 carboxybenzaldehyde, or a mixture of any two or more thereof. No solid TPA is formed during the reaction in contrast to previous manufacturing methods that utilize acidic solvents and precipitate TPA as it forms. By avoiding the direct precipitation of TPA during formation, the present methods avoid many shortcomings of the conventional manufacturing methods used to produce TPA. In particular, the present methods do not require additional purification steps to remove reaction byproducts; film grade TPA can be obtained directly from starting material in a one-step process. | 03-05-2009 |
20090088586 | Catalyst and Method For Preparing Aromatic Carboxylic Acids - The invention is directed to a catalytic principle based on zeolite crystallites attached to support or incorporated in a matrix and a catalytically active principle incorporated in the zeolite, the said crystallites having a diameter of between 20 and 300 nm and said catalytically active principle having a formula corresponding to: CoMn2(O)(R—COO)6 L1k1 L2k2 wherein: R is an optionally substituted C1-C4 alkyl; L1 is an optionally substituted nitrogen containing carboxylic acid or salts thereof; L2 is selected from the group consisting of H2O, an optionally substituted C1-C4 alkyl containing carboxylic acid, an optionally substituted C5-C6 cycloalkyl or heterocycle, an optionally substituted C5-C6 heteroaryl or aryl; and k1+k2=3; wherein the zeolite has an Si/Al atomic ratio of at least 8, as well as to a method for the oxidation of alkyl aromatics compounds employing the catalytic principle | 04-02-2009 |
Hermann De Meyer, Brasschaat BE
Patent application number | Description | Published |
---|---|---|
20130119667 | JET ENGINE WITH CARBON CAPTURE - A method for producing electrical power and capture CO | 05-16-2013 |
20130205796 | HEAT INTEGRATION IN CO2 CAPTURE - A power plant for combustion of carbonaceous fuels with CO | 08-15-2013 |
Kurt Mark Anthony De Meyer, Beerse BE
Patent application number | Description | Published |
---|---|---|
20150031784 | METHOD TO PREVENT DEACTIVATION OF METAL CATALYSTS IN CATALYTIC POLYMERISATION PROCESSES - The present invention relates to a method to prevent deactivation of the metal catalyst in a catalytic polymerisation process of polymeric binders whereby pyrithione biocides are present which method comprises the addition of a Zn, Cu or Na salt selected from Zn, Cu or Na salts of fatty acids such as e.g. Zn, Cu or Na octoate, Zn, Cu or Na acrylate, Zn, Cu or Na neodecanoate, or Zn, Cu or Na salts of beta diketones such as e.g. Zn, Cu or Na acetylacetonate. | 01-29-2015 |
Marijke De Meyer, Sledinge BE
Patent application number | Description | Published |
---|---|---|
20120018058 | PROCESS FOR MANUFACTURING A COLD ROLLED TRIP STEEL PRODUCT - The present invention is related to a process comprising a cold rolling step, for the production of uncoated, electro-galvanised or hot dip galvanised TRIP steel products, | 01-26-2012 |
Nathalie De Meyer, Toronto CA
Patent application number | Description | Published |
---|---|---|
20090240777 | METHOD AND SYSTEM FOR PROTECTING MESSAGING CONSUMERS - The present invention is directed to a system, method, and computer-program product for protecting messaging consumers. According to one embodiment of the invention, a method for protecting messaging consumers can be provided. The method can include intercepting a message prior to arrival at a destination, comparing the message to one or more known message structures to determine the message structure, and determining if a message has a valid message structure for the destination. Intercepting a message prior to arrival at a destination may intercepts a message on a queue before the message is consumed by a consumer. Comparing the message to known message structures compares a message to message schemas, for example, XML schema, Java object definition or C structure format. | 09-24-2009 |
Peter De Meyer, Sint-Laureins BE
Patent application number | Description | Published |
---|---|---|
20110258772 | BED SYSTEM - The present invention relates to a bed system which comprises a mattress supporting structure. The bed system comprises a height adjustment system which comprises at least one rotatable multi-angular transverse beam comprising a plurality of transverse beam sides and an eccentric rotation axis which is accessible from outside said outer frame. The height adjustment system further comprises a rotation imparting member which is accessible from outside the outer frame and provided for rotating said at least one rotatable transverse beam about its eccentric axis. Said rotation imparting member is displaceable between a first and a second position. The first position is provided for rotating said at least one rotatable transverse beam about its eccentric axis and said second position is provided for blocking said at least one rotatable transverse beam in a desired height position with respect to said outer frame. | 10-27-2011 |
Sandra De Meyer, Beerse BE
Patent application number | Description | Published |
---|---|---|
20080287488 | Use of a Sulfonamide Compound For Improving the Pharmacokinetics of a Drug - A method for improving the pharmacokinetics of drugs, which are metabolized by cytochrome P450 monooxygenase is disclosed. More specifically it relates to a method for improving the pharmacokinetics of retroviral protease inhibitors and in particular for improving the pharmacokinetics of human immunodeficiency virus (HIV) protease inhibitors. A pharmaceutical composition and its use in the manufacture of a medicament for the inhibition or treatment of an HIV infection or AIDS in a human being are also part of the invention. | 11-20-2008 |
20100173282 | MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e. correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management. | 07-08-2010 |
20110166061 | LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTION - The present invention is concerned with This invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV) with long duration of action for the treatment of the respective viral infections. | 07-07-2011 |
20120258448 | MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management. | 10-11-2012 |
20140127797 | MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management. | 05-08-2014 |
Simon De Meyer, Heule BE
Patent application number | Description | Published |
---|---|---|
20090311267 | Inhibition of VWF - GPIb/V/IX interaction and platelet-collagen interaction for prevention and treatment of cerebral attacks - The invention relates generally to an anti-thrombotic treatment of occlusive syndromes in the cerebral vascular system causing cerebral infarct due to stroke or ischemic stroke, which is a major cause of death and permanent disability in industrialized countries. More particularly, the invention relates to a system and method of preventing and treating such occlusive syndromes in the cerebral vascular by inhibiting initial adhesion/attachment of platelets to the endothelium by preventing or inhibiting binding of von Willebrand factor to platelet glycoprotein Ib by administration of a subject in such need anti-glycoprotein Ib monovalent antibodies and/or anti-vWF monovalent antibodies, rather than by blocking the common pathway of platelet aggregation by blockade of platelet aggregation with anti-glycoprotein IIb/IIIa. | 12-17-2009 |
Simon De Meyer, Hooglede BE
Patent application number | Description | Published |
---|---|---|
20140199329 | METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS - Embodiments of the technology described herein are based upon the discoveries that neturophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries. | 07-17-2014 |